Leukocytosis Associated with Clozapine Treatment: A Case Series and Systematic Review of the Literature
Background and Objectives: Clozapine is the only antipsychotic approved for treatment-resistant schizophrenia. Despite its superior efficacy profile as compared with other antipsychotics, clozapine remains underutilized. Clozapine monitoring systems clearly describe the proposed management of clozap...
Main Authors: | Pasquale Paribello, Mirko Manchia, Massimo Zedda, Federica Pinna, Bernardo Carpiniello |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1648-9144/57/8/816 |
Similar Items
-
Leukocytosis associated with clozapine in elderly patient
by: Javed Ather Siddiqui, et al.
Published: (2016-01-01) -
Transient leukocytosis in Emergency Room: an overlooked issue
by: Giampiera Bertolino, et al.
Published: (2017-03-01) -
Quo Vadis Clozapine? A Bibliometric Study of 45 Years of Research in International Context
by: Francisco López-Muñoz, et al.
Published: (2015-09-01) -
Neutrophilia: what is hidden under the mask
by: Vatutin N.T., et al.
Published: (2014-06-01) -
Management of obsessive compulsive disorder induced by the use of clozapine
by: Yunus Emre Donmez, et al.
Published: (2019-06-01)